< Go Back

Blue Oak Pharmaceuticals


USA, Massachusetts, Waltham
Small Molecule

Blue Oak Pharmaceuticals is committed to finding the next generation of drugs for the brain disorders. They believe that first-in-class drugs will be discovered by integrating novel, custom-designed privileged chemotypes with validated in vivo systems neurobiology assays and brain circuit imaging. Blue Oak drug hunters are experts in the systems neurobiology of brain disorders, medicinal chemistry and informatics. Their industry-leading productivity integrates a “global research team” that integrates established partners with cutting-edge technologies in behavioral profiling, synthetic chemistry and brain imaging. They will advance first-in-class clinical candidates to early phase proof-of-concept studies using translational medicine biomarkers for brain circuit activity.